Thyroid problems in pregnancy: Tests and Recommendations

3 weeks ago

1. In Pregnancy: What Changes Are Physiological, and What Signals Disease?

Pregnancy produces substantial physiological changes in thyroid function because maternal thyroid hormone production must adapt to increased metabolic demands and to the needs of the developing fetus. Consequently, thyroid function tests in a healthy pregnant woman do not necessarily have the same values as those in a non-pregnant woman.

Pregnancy causes major changes in thyroid physiology, including ↑ TBG, increased maternal T4 requirements, and transient TSH suppression by hCG in early pregnancy. The maternal thyroid must increase hormone production to meet the increased demands of pregnancy, driven partly by placental thyroid hormone metabolism and fetal needs. Iodine deficiency impairs this adaptation, causing relative hypothyroxinemia and maternal/fetal goiter, with severity depending on the degree of deficiency. Adequate iodine intake (~200 μg/day) during pregnancy helps prevent these complications.1

Thyroid disorders can have a significant impact on pregnancy outcomes. In women of reproductive age, thyroid disease is the second most common endocrine disorder, and when left untreated, it can increase the risk of miscarriage, placental abruption, hypertensive complications, and fetal growth restriction. This makes timely recognition crucial. Current guidelines support targeted screening of women at increased risk, including those with previous thyroid disease, autoimmune conditions, type 1 diabetes, thyroid medication use, or a family history of autoimmune thyroid disease. Early detection and appropriate treatment can help protect both maternal and fetal health. 2

2. Maternal Thyroid Dysfunction: How Does It Influence Pregnancy and Fetal Outcomes?

A study by Vamja et al. found that thyroid disorders affected 33.9% of pregnant women, with hypothyroidism being more common than hyperthyroidism. Hypothyroidism was associated with greater maternal complications, particularly preeclampsia, gestational hypertension, postpartum haemorrhage, and anaemia. Importantly, thyroid dysfunction also had implications for the newborn, with preterm birth, NICU admission, respiratory distress, and low APGAR scores reported in both hypo- and hyperthyroid pregnancies. A small gland, but a big influence on pregnancy outcomes.3

Thyroid Disorders in Pregnancy: What Can Go Wrong?

1. Hypothyroidism: When the Thyroid Falls Behind
2. Hyperthyroidism: When the Thyroid Goes Into Overdrive
3. Goiter: When the Thyroid Enlarges
4. Thyroid Nodules: Finding a Lump During Pregnancy
5. Thyroid Cancer: When Pregnancy Meets a Thyroid Nodule
6. Postpartum Thyroiditis: When the Thyroid Changes After Birth

Key diagnostic patterns are thereforE:

WhatsApp Image 2026 10 13 at 12.06.54 PM

3. Who Should Be Tested? Rethinking Thyroid Screening in Pregnancy.

The question of “screen everyone or screen selectively?” remains important in pregnancy. Current guidance emphasizes risk-based evaluation, while the role of universal thyroid screening continues to be debated. Women with a personal history of thyroid disease, goiter, thyroid surgery or treatment, autoimmune disease (including type 1 diabetes), a family history of thyroid disease, or clinical features suggesting thyroid dysfunction warrant particular attention.
Not every pregnant woman presents with obvious thyroid symptoms—so knowing who is at risk can make the difference between missed disease and timely diagnosis.

High-risk women to consider for thyroid testing:
Previous thyroid disease or thyroid surgery
Previous treatment with antithyroid drugs or thyroid hormone
Goiter or thyroid nodules
Family history of thyroid disease
Type 1 diabetes or other autoimmune disease
Previous thyroid antibody positivity
Symptoms or signs suggestive of thyroid dysfunction
History of pregnancy loss, preterm delivery, or infertility may also be relevant depending on the guideline.

Universal vs targeted screening; Universal screening means testing every pregnant woman, whereas targeted screening/case-finding tests women with recognized risk factors. Earlier ATA guidance found insufficient evidence to recommend for or against universal TSH screening, while recommending testing in women at increased risk factors.5

4. Beyond TSH: Which Thyroid Tests Matter in Pregnancy—and When?

Risk Of Hashimotos And Pregnancy

TSH may be the starting point, but it is not the whole story. Pregnancy changes thyroid physiology and can alter the interpretation of thyroid tests, making pregnancy- and trimester-specific reference ranges particularly important.
o TSH — the key starting test: The best biochemical marker of maternal thyroid status during pregnancy.
o FT4 — confirms thyroid dysfunction: Helps distinguish overt from subclinical thyroid disease, although interpretation requires pregnancy- and assay-specific reference ranges.
o Total T4/T3 — useful in selected situations: Pregnancy raises total T4 and T3 because of increased TBG. Total T4 can be useful when FT4 results are difficult to interpret; T3 is mainly useful when evaluating hyperthyroidism.
o TPOAb — looks for thyroid autoimmunity: Particularly useful in selected women with elevated/high-normal TSH, recurrent miscarriage, autoimmune disease, or a family history of thyroid autoimmunity.
o TRAb — important in Graves’ disease: Helps identify women whose maternal thyroid-stimulating antibodies may have implications for the fetus.6

In a Nutshell, TSH may open the door to diagnosis, but FT4, TPOAb and TRAb tell us what is really happening behind it.

TRAb; TRAb stands for thyrotropin receptor antibodies. - They are autoantibodies directed against the TSH (thyrotropin) receptor and are particularly important in Graves’ disease. During pregnancy, TRAb can cross the placenta and stimulate or, less commonly, block the fetal thyroid, so they can be clinically important even when the mother is currently euthyroid.

5.The Pregnancy-Specific Reference Range: Can We Interpret TSH and FT4 Using Standard Laboratory Values?

The short answer is no. Standard laboratory reference ranges are designed for the non-pregnant population and fail to reflect the dramatic physiological shifts that occur during gestation.

Why Standard Ranges Fall Short?

During pregnancy, surging levels of human chorionic gonadotropin (hCG) physically stimulate the thyroid gland. Because hCG shares structural similarities with Thyroid-Stimulating Hormone (TSH), it temporarily suppresses maternal TSH levels—particularly during the first trimester. Simultaneously, elevated estrogen increases Thyroid-Binding Globulin (TBG), which alters total hormone concentrations.
As a result, using standard, non-pregnant reference ranges can easily lead to misdiagnosis:
· False Positives: A healthy, low TSH driven by normal hCG activity might be misdiagnosed as hyperthyroidism.
· Missed Diagnoses: A "normal" baseline TSH might actually represent mild hypothyroidism in a pregnant patient.
The Old Rules Don’t Work Here
When pregnancy begins, the body completely rewrites its rules—and standard blood tests simply can't keep up. Relying on regular lab ranges isn't just a mistake; it's a dangerous game of missing hidden red flags or sounding false alarms.

To prevent misdiagnosis, major medical consensus—including the latest American Thyroid Association (ATA) guidelines—recommends using trimester-specific and population-specific reference ranges calculated from healthy local pregnant women.
Because thyroid levels vary wildly around the globe, expert guidelines demand a sharp recalibration:
o Drop the lower limit by 0.4 mU/L in early pregnancy.
o Slash the upper limit by 0.5 mU/L, capping TSH tightly at 4.0 mU/L for most patients.5,6
Therefore, In those critical first months, a single point off can change everything. Standard cutoffs are off the table—pregnancy demands its own set of rules.

From Diagnosis to Follow-Up: Treating and Monitoring Thyroid Disease

Managing thyroid health during pregnancy demands quick action and precise timing to protect both mother and baby.
So, according to the latest American Thyroid Association (ATA) Guidelines, levothyroxine doses should be adjusted promptly during early pregnancy, and TSH monitored every four weeks throughout the first half of gestation." The detailed plans would be as follows;

1. Hypothyroidism (Levothyroxine)

· Verify First: For mild TSH elevations (<6 mU/L), retest before treating—over 50% normalize on their own.
· Increase Dose Early: Women already taking Levothyroxine usually need a 25%–50% dose increase in the first trimester.
· Targeted Care: Routine therapy isn't recommended for euthyroid women with thyroid antibodies (TPOAb+) or isolated low T4.

2. Hyperthyroidism (Antithyroid Drugs)

· Trimester-Based Selection: Use Propylthiouracil (PTU) in the first trimester to minimize birth defect risks; switch to Methimazole (MMI) in the second/third trimesters to protect the liver.
· Lowest Dose: Keep maternal Free T4 at or slightly above the upper limit of normal.

3. Monitoring Blueprint

· First Half (Up to Week 20): Test TSH and Free T4 every 4 weeks.
· Second Half: Test at least once per trimester, or 4–6 weeks after any dose adjustment.
· Graves' Disease: Monitor TRAb antibodies to assess fetal risks.

4. Postpartum Reset

· Lower Dose Immediately: Drop Levothyroxine back to pre-pregnancy levels right after delivery.
· 6-Week Follow-Up: Re-check thyroid levels at 6 weeks postpartum.
· Watch for Shifts: Be aware of Postpartum Thyroiditis (temporary high phase followed by a low phase) during the first year.5,6

Bottom line

Hypothyrodism

Thyroid health during pregnancy is all about balance, timing, and individual care. Because your body’s needs shift rapidly from month to month, standard "one-size-fits-all" lab ranges simply don't apply.
If you're planning a pregnancy or are currently expecting, early risk-based screening, proper lab interpretation, and targeted monitoring are your best tools for a safe, healthy journey.

Always work closely with your healthcare provider to ensure your treatment plan is tailored specifically to you and your baby.4,5,6

Accurate thyroid function testing and pregnancy-appropriate interpretation of results are important in identifying and monitoring thyroid disorders during pregnancy.

With over a decade of diagnostic experience in Nepal, National Path Lab supports clinicians with reliable laboratory testing to help guide maternal care.

References

1. Glinoer D. What happens to the normal thyroid during pregnancy? Thyroid. 1999;9(7):631-5. doi:10.1089/thy.1999.9.631.

2. Carney LA, Quinlan JD, West JM. Thyroid disease in pregnancy. Am Fam Physician. 2014;89(4):273-8. Erratum in: Am Fam Physician. 2014;90(1):8. PMID:24695447.

3. Vamja R, M Y, Patel M, Vala V, Ramachandran A, Surati B, et al. Impact of maternal thyroid dysfunction on fetal and maternal outcomes in pregnancy: a prospective cohort study. Clin Diabetes Endocrinol. 2024;10(1):50. doi:10.1186/s40842-024-00212-6.

4. Pearce EN. Thyroid regulation and dysfunction in the pregnant patient. In: Feingold KR, Adler RA, Ahmed SF, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Updated 2026 Jul 6.

5. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017 Mar;27(3):315-389. doi: 10.1089/thy.2016.0457.

6. Korevaar TIM, Leung AM, Alexander EK, Bliddal S, Boelaert K, Brenta G, et al. American Thyroid Association 2026 guidelines for thyroid disease in preconception, pregnancy, and postpartum. Thyroid. 2026;36(5):481-544. doi:10.1177/10507256261445624.

By Dr. Chetna Nihure, MD, Pathology